Neurturin (NRTN), a member of the GDNF family of ligands (GFL), is currently investigated in a series of clinical trials for Parkinson's disease. NRTN signals through its cognate receptor GFRα2 and co-receptor RET to induce neurite outgrowth, but the underlying mechanism remains to be better understood. STAT3 was previously shown to be activated by oncogenic RET, independent of ligand and GFRα. In this study, we demonstrated that NRTN induced serine 727 but not tyrosine 705 phosphorylation of STAT3 in primary cortical neuron and neuronal cell lines. Remarkably, STAT3 phosphorylation was found to be mediated specifically by GFRα2c and RET9 isoforms. Furthermore, serine but not tyrosine dominant negative mutant of STAT3 impaired NRTN induced neurite outgrowth, indicative of the role of STAT3 as a downstream mediator of NRTN function. Similar to NGF, the NRTN induced P-Ser-STAT3 was localized to the mitochondria but not to the nucleus. Mitochondrial STAT3 was further found to be intimately involved in NRTN induced neurite outgrowth. Collectively, these findings demonstrated the hitherto unrecognized and novel role of specific GFRα2 and RET isoforms in mediating NRTN activation of STAT3 and the transcription independent mechanism whereby the mitochondria localized P-Ser-STAT3 mediated NRTN induced neurite outgrowth.
Introduction
Neurturin (NRTN) is a member of the glial cell line-derived neurotrophic factor (GDNF) family of ligands (GFLs) which have been shown to support the growth, maintenance and differentiation of both central and peripheral nervous systems [1] . Multiple clinical trial evaluating NRTN based gene therapy for Parkinson's disease are currently underway (Phase II, Ceregene, NCT00985517 etc.). NRTN transduces signals through a multi-component receptor complex consisting of GPI anchored GDNF family receptor alpha 2 (GFRα2) and trans-membrane co-receptors RET (RE arranged during Transformation) or neural cell adhesion molecule (NCAM) [2] [3] [4] . NRTN-GFRα2 signalling is crucial for neuronal development. Mice lacking NRTN and GFRα2 signalling suffer from deficits in target innervations in both sympathetic [5] and parasympathetic neurons [6] . Furthermore, in GFRα2 knockout mouse, NRTN stimulation failed to initiate axonal outgrowth of DRG neurons, supporting the physiological role of GFRα2 in neuronal differentiation [7] . Multiple alternatively spliced isoforms of GFRα2 have been reported [8] and were found to be widely expressed in the nervous system. Interestingly, NRTN stimulation of GFRα2a and GFRα2c induced neurite outgrowth whereas ligand stimulation of GFRα2b inhibited neurite outgrowth, highlighting the distinct biochemical and neuritogenic functions of these receptor isoforms [9, 10] . Similarly, RET [11] and NCAM isoforms [12] were also found to exert distinct functions in neuronal systems. Understanding the combinatorial interactions between GFRα2, RET and NCAM isoforms will provide novel insights into the diverse functions of NRTN and the underlying signalling network.
Signal Transducer and Activator of Transcription 3 (STAT3) is a classic transcription regulator that mediates a myriad of biological functions in multiple cellular systems [13] . In neuronal systems, STAT3 plays critical roles during neural development and mediates the protective and regenerative effects of multiple neurotrophic factors upon nerve injuries [13] . The canonical pathway of STAT3 activation involves ligand induced phosphorylation of tyrosine 705 residue (P-Tyr-STAT3), resulting in STAT3 nuclear translocation and activation of target gene transcription [14] . STAT3 can also be phosphorylated at serine 727 (P-Ser-STAT3), but its functional significance remains controversial. Serine phosphorylation can enhance or suppress the transcriptional activity of tyrosine phosphorylated STAT3 in a cell context dependent manner [15, 16] . More recently, STAT3 has also been shown to localize to the mitochondria and exert functions independent of its transcriptional activities [17, 18] . GFL independent activation of STAT3 by oncogenic RET has been observed. Depending on the type of mutations, different oncogenic RET (PTC, MEN2 or FMTC) are capable of inducing either specific tyrosine phosphorylation or dual tyrosine and serine phosphorylation of STAT3 [19, 20] . In addition, the signaling pathways mediating oncogenic RET induced STAT3 phosphorylation vary across cell types. In ARO cells, the intrinsic kinase activity of oncogenic RET alone was found to be sufficient to induce STAT3 phosphorylation [21] . In other cell models, mutant RET activated a Src/JAK/STAT3 pathway which was shown to be independent of ligand [22] . From these studies, a pertinent and obvious question is whether STAT3 can be activated by the interactions of the wild type RET, as a co-receptor, with GFLs and GFRα.
In this study, we tested the hypothesis that STAT3 can be activated by NRTN-GFRα2 signaling and may in turn mediate the neuritogenic functions of NRTN. STAT3 was found to be serine mono-phosphorylated upon NRTN stimulation. The involvement of specific GFRα2 and RET isoforms in NRTN induced P-Ser-STAT3 was further investigated in multiple cell models. Moreover, serine but not tyrosine dominant negative mutant of STAT3 was found to impair NRTN induced neurite outgrowth. Similar to our earlier study on NGF, NRTN induced P-Ser-STAT3 was found to be localized to the mitochondria but not the nucleus. The mitochondrial P-Ser-STAT3 was further shown to be intimately involved in NRTN induced neurite outgrowth. To the best of our knowledge, this is the first report demonstrating the activation of STAT3 by a GFL through the interaction of the wild type RET and a GFRα. Our findings further illustrated the distinct functions of GFRα2 and RET isoforms and showed the transcription-independent mechanism whereby mitochondria localized STAT3 mediates NRTN induced neurite outgrowth.
Materials and methods

Cell culture
The murine neuroblastoma cell line Neuro2A cells (American Type Culture Collection; catalog # CCL-131) were grown in DMEM (Sigma, St. Louis, MO) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Sigma), 100 units/ml penicillin (Pan Biotech, Germany) and 100 μg/ml streptomycin (Pan Biotech), at 37°C in a humidified atmosphere with 5% CO 2 . The rat pheochromocytoma cell line PC12 cells (American Type Culture Collection; catalog # CRL-1721) were grown in DMEM (Sigma, St. Louis, MO) supplemented 10% heat-inactivated FBS, 5% Horse Serum (HS, Hyclone, Logan, UT), 100 units/ml penicillin and 100 μg/ml streptomycin. For studies on ligand induced signaling activation and neurite outgrowth, Neuro2A and PC12 cells were serum starved in DMEM with 1/20 of original serum content (0.5% FBS for Neuro2A and 0.25% HS, 0.5% FBS for PC12) for 12-16 h before stimulated with 50 ng/ml of NRTN (PeproTech, London, UK) or IL6 (PeproTech). For inhibitor studies, the cells were pre-treated with U0126 (Promega), SP600125 (Tocris, Bristol, UK), SB203580 (Tocris), PP2 (Tocris), SU6656 (Sigma), or Gö6983 (Sigma) for 1 h before stimulated with NRTN in the presence of these inhibitors.
Primary culture
Rat primary cortical neurons were isolated from embryonic day 18 (E18) rat embryos, as described previously [23] . Briefly, the cortices were dissected and dissociated in Hank's balanced salt solution (Sigma), and plated on poly-D-lysine (Sigma) coated culture plates in Minimal essential medium (MEM, Sigma) supplemented with glucose (0.6% wt/vol, Sigma) and 10% FBS. After 24 h, MEM was replaced by Neurobasal medium (Invitrogen, Carlsbad, CA) containing B27 supplement (Invitrogen), 2 mM glutamine (Invitrogen), 100 units/ml penicillin and 100 μg/ml streptomycin and continued to culture for 48 h at 37°C in a humidified atmosphere with 5% CO 2 . On DIV 3 (3 days in vitro), primary cortical neurons were washed once with Neurobasal medium without B27 and kept in the same medium for 3 h before stimulated with 100 ng/ml NRTN. All procedures were performed according to the guidelines issued by the National University of Singapore Institutional Animal Care & Use Committee (IACUC). This study was approved under a broader project titled "Mechanism elucidation and application of global Transcriptional Machinery Engineering (gTME) to the modulation of the isoprenoid pathway for biosynthesis of pharmaceutical" and given the animal work permits (072/09).
Construction of retroviral vectors containing wild type and mutant STAT3 and transient transfection
The vector construction has been described previously [23] . The wild type and three mutant forms of STAT3a (Ser727Ala, Ser727Glu, Tyr705Phe) were kindly provided by Dr. Cao Xinming (Institute of Molecular and Cellular Biology, Singapore). For transient expression studies, wild type and mutant STAT3a constructs were sub-cloned into a modified murine retroviral pQCXI vector (Clontech, Mountain View, CA) that harbors an eGFP-coding sequence under the control of an internal ribosomal entry site (pQCXI-eGFP). For mitochondria targeted STAT3 constructs, the mitochondrial targeting sequence (MTS) from cytochrome c oxidase subunit VIII was first cloned and fused to the 5′ of wild type and mutant STAT3a by assembly PCR and subcloned into the retroviral pQCXI-P vector containing puromycin resistance gene as selection marker.
Transient transfection of Neuro2A cells
The wild-type and mutant STAT3-eGFP co-expression constructs were transiently transfected into Neuro2A cells using Transfectin (BioRad) at a ratio of 8 μl Transfectin to 4 μg cDNA per 100,000 cells. Neuro2A cells were incubated with the transfection mixture for 12 h and allowed to recover for 24 h in complete medium before experimentation. Successfully transfected cells were identified through eGFP expression. For knockdown experiments, small interfering RNA (siRNA) duplexes for murine RET (sc-36405) and NCAM (sc-36017) were purchased from Santa Cruz. Briefly, subconfluent cells (50-80%) were transfected with siRNA duplexes (40 nM) using Transfectin (Bio-Rad) for 24 h. Cells were serum deprived for 12-16 h before stimulation with 50 ng/ml NRTN to induce signaling activation and neurite outgrowth.
Stable transfection of Neuro2A and retroviral infection of PC12 cells
The establishment of Neuro2A cells stably expressing GFRα2 isoforms has been described previously [10] . Retroviral vector pQCXIN (Clontech, Palo Alto, CA) carrying neomycin resistance gene was used to clone the open reading frames (ORFs) of mouse GFRα2a (GenBank accession number: AF079108), GFRα2b (GenBank accession number: AF079107) and GFRα2c (GenBank accession number: AF002701). Retroviral vector pQCXIH (Clontech) carrying hygromycin B resistance gene was used to clone mouse ORF of RET9 (GenBank accession number: AY326397) and RET51 (GenBank accession number: AF209436). Retroviral pQCXI-P vector carrying puromycin resistance gene was used to clone MTS-STAT3 constructs. Plat-E cells were transfected with these retroviral vectors using FuGene 6 (Roche, Germany). Active retroviruses were collected from supernatants and used to infect PC12 cells in the presence of 8 μg/ml of polybrene. PC12 cells were first infected with combinations of pQCXIN and pQCXIH vectors and selected over 2 month in complete medium supplemented with 0.4 mg/ml G418 and 0.1 mg/ml hygromycin B. The selected PC12 cells were then infected with retroviruses carrying different MTS-STAT3 mutants and further selected over 2 months with 2 μg/ml Puromycin (Sigma). These engineered PC12 cells were shown to stably overexpress wild type and mutant MTS-STAT3 in the mitochondrial but not in the cytosolic fraction [23] .
RNA extraction and reverse transcription
Total RNA from primary neurons or cultured PC12 and Neuro2A cells was isolated using TRI-Reagent (Sigma) according to manufacturer's instruction. The integrity of isolated total RNA was validated by denaturing agarose gel electrophoresis and the concentration measured by Nanodrop 2000 (Thermo Scientific). Two micrograms of total RNA were reverse transcribed using ImPromII reverse transcriptase (Promega) and 0.5 μg random hexamer for 60 min at 42°C according to manufacturer's instruction. The reaction was terminated by heating at 70°C for 5 min.
Primers and qPCR
Real-time qPCR using SYBR Green I was performed on the CFX96 (Biorad, Hercules, CA) in a total volume of 25 μl in 1× XtensaMix-SG™ (BioWORKS, Singapore), containing 2.5 mM MgCl 2 , 200 nM of primers and 0.5 U of KlearTaq DNA polymerase (KBiosciences, UK). Real-time qPCR was carried out after an initial denaturation for 10 min at 95°C followed by 40 cycles of 30 s denaturation at 95°C, 30 s annealing at 60°C and 30 s extension at 72°C. Melt curve analyses were performed at the end of reaction to verify the identity of the products. The threshold cycles (Ct) were calculated using the CFX manager v1.6 (Biorad). All realtime PCR quantification was carried out simultaneously with linearized plasmid standards and non-template controls. The expression levels of GFRα2, RET isoforms and NCAM were interpolated from standard curves and normalized to the expressions of GAPDH in the same samples. The primer sequences are as follows:
Western blot analysis
Primary cortical neurons, PC12 and Neuro2A cells were washed once with PBS and subsequently lysed in lysis buffer containing 2% (w/v) SDS. Protein concentrations were quantified using the microBCA assay (Pierce, Rockford, IL). The protein samples were separated by SDS-PAGE gel and incubated with antibodies against Phospho-STAT3-ser727 (#9134, Cell Signalling Technology [CST], Beverly, MA), Phospho-STAT3-tyr705 (sc-8059, Santa Cruz), Pan-STAT3 (#9132, CST), Phospho-ERK1/2 (#9101, CST), Pan-ERK1/2 (#9102, CST), PARP (#9542, CST), VDAC (#4866, CST) or SOD1 (sc-11407, Santa Cruz). The protein bands were developed with Immobilon Western Chemilum HRP Substrate (Millipore, Billerica, MA) on ChemiDoc XRS system (Biorad). The band intensities were quantified with Quantity One 1-D Analysis software v4 (Biorad).
Preparation of nuclear and cytosolic extracts
The nuclear and cytosolic extracts were prepared using NE-PER® Nuclear and Cytoplasmic Extraction Reagents (Pierce), according to manufacturer's instruction. Briefly, PC12 and Neuro2A cells were washed twice with ice-cold PBS and harvested by gentle scraping. Cells were pelleted by centrifugation at 500 ×g for 5 min, resuspended in ice cold CER I and incubated on ice for 10 min. The cells were then lysed by addition of ice cold CER II and centrifuged for 5 min at 16,000 ×g to separate the cytosolic fraction (supernatant) from the nucleus (pellet). The pellet was resuspended in ice cold NER and incubated on ice for 40 min with occasional vortexing (15 s after every 10 min of incubation). The nuclear extracts (supernatant) were separated from the debris by centrifugation at 16,000 g for 10 min.
Preparation of mitochondrial and cytosolic extracts
Mitochondrial and cytosolic extracts were prepared from PC12 and Neuro2A cells using differential centrifugation, as previously described [23] . Briefly, the cells were washed twice with ice-cold phosphate buffer saline (PBS) and harvested by gentle scraping. Cells were pelleted by centrifugation at 500 ×g for 5 min and resuspended in ice cold mitochondria extraction buffer (50 mM HEPES pH 7.4, 68 mM sucrose, 200 mM D-mannitol, 50 mM KCl, 2 mM MgCl 2 , 5 mM EDTA, 10 μg/ml aprotinin, 2 μg/ml pepstatin A, 10 μg/ml leupeptin, 50 mM NaF, 0.5 mM sodium vanadate, 20 mM glycerol phosphate) and incubated on ice for 15 min to allow swelling. The cells were dounce homogenized with 60 strokes. The unbroken cells and nuclei were removed by centrifugation at 800 ×g for 10 min at 4°C. The supernatants were further centrifuged at 10,000 ×g for 30 min at 4°C to obtain the crude mitochondrial fraction. The resulting supernatants were collected as the cytosolic extracts and the crude mitochondrial pellet was washed once with extraction buffer and collected by centrifugation at 10,000 ×g for 30 min at 4°C.
Differentiation and assessment of neurite outgrowth
Neuro2A cells were seeded on 12-well cell culture plates (NUNC, Finland) in DMEM supplemented with 10% FBS overnight. Upon attachment, the cells were serum deprived (DMEM supplemented with 1% FBS) for 12-16 h. Control and transfected cells were then treated with 50 ng/ml NRTN for 24 h to induce neurite outgrowth. For transient STAT3 mutant expression experiments, infected cells were identified by eGFP expression and those eGFP positive cells bearing at least one neurite with the length equivalent to two cell-body length were scored. More than 60 eGFP positive cells from three biological replicates were counted. Stably infected PC12 cells were seeded on poly-D-lysine coated 12-well cell culture plates overnight in DMEM supplemented with 10% FBS and 5% HS. Upon attachment, the cells were serum starved (DMEM supplemented with 0.5% FBS and 0.25%HS) for 12-16 h. The cells were then treated with 50 ng/ml NRTN for 48 h to induce neurite outgrowth. For inhibitor studies in both cells, serum deprived cells were pre-treated with selected pharmacological inhibitors for 1 h before NRTN stimulation. After 24 or 48 h, the cells bearing at least one neurite with the length equivalent to two cell-body length were scored. More than 300 cells from three biological replicates were counted to obtain the mean and standard deviation. For studies of mitochondria targeted STAT3 mutants, NRTN induced neurite outgrowth in PC12 clones stably expressing different mutants were analyzed using HCA-Vision (CSIRO, AU). Briefly, control and NRTN treated PC12 cells were fixed with 4% paraformaldehyde (PFA; BDH Laboratory, UK). The cell bodies and neurites were stained with Imperial Stain (Pierce) and the nuclei with 1 μg/ml Hoescht 33342 (Sigma). All images of control and NRTN treated cells were acquired with identical imaging parameters using a Zeiss Axio Observer Z1 Inverted Microscope (Carl Zeiss, Germany). The images were batch analyzed using HCA-Vision through a 3-step analysis including Neuron Body Detection, Neurite Detection and Neurite Analysis, with identical parameters. Significant differences in neurite outgrowth between wild type and STAT3 mutant expressing PC12 cells were calculated using the paired Student's t-test. A value of p b 0.05 was considered significant (**p b 0.01; *p b 0.05).
Immunocytochemistry
Control and NRTN treated Neuro2A, PC12 Cells and rat embryonic cortical neurons were fixed with 4% paraformaldehyde in PBS for 15 min at 37°C, subsequently permeabilized in 0.5% Triton-X100/ PBS and blocked with normal goat serum (1:10; Dako, Glostrup, Denmark) in 0.5% Triton X-100/ PBS for 45 min at 37°C. The cells were then incubated with primary antibodies against Phospho-STAT3-ser727 (CST #9134, 1:100 dilution) or GRIM-19 (Invitrogen #438900, 1:100 dilution) in 0.3% Triton X-100/ 1% BSA/ PBS overnight at 4°C and washed three times in PBS. Subsequently, the cells were incubated with goat antirabbit or goat anti-mouse fluorescent secondary antibody (Alexa Fluor 488/ 596; Invitrogen, CA) diluted 1:400 in 0.3% Triton X-100/ 1% BSA/ PBS for 2 h at 37°C. The cells were washed three times in PBS and mounted. For Mitotracker labeling, live Neuro2A or PC12 cells were pre-incubated with 200 nM MitoTracker® Red CMXRos (Invitrogen M7512) for 10 min before NRTN stimulation. Image acquisition was performed using the Zeiss LSM710 with Axio Observer.Z1 confocal microscope equipped with fluorescence detection (Oberkochen, Germany). Images of control and NRTN stimulated samples were taken with identical laser and optical settings. Colocalization coefficients (Pearson correlation coefficient) between P-Ser-STAT3 and MitoTracker or P-Ser-STAT3 and GRIM-19 were analyzed with Zeiss ZEN software (v2010).
Results
NRTN induced STAT3 phosphorylation in cortical neuron expressing multiple receptor isoforms
NRTN has been reported to exert neurotrophic effects on cortical neurons [24] , which express high levels of GFRα2 [10] , making these neurons a suitable model to investigate NRTN function and signaling. In order to determine the expression levels of GFRα2 and its coreceptors (RET and NCAM), total RNA was isolated from primary cortical neurons (E18) and measured by RT-qPCR. All three isoforms of GFRα2, GFRα2a, 2b and 2c were expressed at comparable levels in the cultured primary cortical neurons (Fig. 1A) . Co-receptor wise, RET9 isoform was found to be expressed at slightly higher level than RET51, whereas NCAM expression was about ten-fold higher than that of RET9. NRTN stimulation of cultured primary cortical neurons induced rapid phosphorylation of MAP kinase ERK. Intriguingly, NRTN treatment resulted in serine but not tyrosine phosphorylation of STAT3 (Fig. 1B) . These data demonstrated that STAT3 can be activated by a GFL (NRTN) and may be mediated by distinct combinations of receptor isoforms.
GFRα2c but not 2a or 2b mediated NRTN induced STAT3 serine phosphorylation in Neuro2A cells
To test the hypothesis that NRTN induced P-Ser-STAT3 is mediated through specific GFRα2 isoforms, Neuro2A cells were transfected to stably express either GFRα2a, 2b or 2c receptor isoforms (Figs. 1C, S1A ). Neuro2A cells endogenously express both RET and NCAM at levels comparable to that of primary cortical neurons but have negligible levels of GFRα2, making these cells an ideal model to investigate GFRα2 isoform function [10] . These GFRα2 isoform expressing Neuro2A cells were stimulated with NRTN and the phosphorylation of STAT3 were measured. Consistent with the observation in primary cortical neurons, NRTN did not induce tyrosine phosphorylation of STAT3 ( Fig. 1D and F) . Surprisingly, NRTN stimulation of GFRα2c but not 2a or 2b was found to significantly induce sustained serine phosphorylation of STAT3 ( Fig. 1D and E), suggesting NRTN activation of STAT3 was mediated by specific receptor isoform. Since STAT3 is known to mediate the neuritogenic function of neurotrophic factors, we tested if STAT3 is involved in NRTN induced neurite outgrowth. Wild type and mutant STAT3 were transiently expressed in Neuro2A-GFRα2c cells using vector constructs co-expressing enhanced green florescence protein (eGFP) as a marker for gene transfer. STAT3 serine (S727A) but not tyrosine (Y705F) dominant negative mutant was found to significantly attenuate NRTN induced neurite outgrowth ( Fig. 1G and H) . In addition, expression of the STAT3 serine constitutive active mutant (S727E) resulted in a significant enhancement of neurite outgrowth, lending further evidence that P-Ser-STAT3 was involved in NRTN induced neurite outgrowth. It is noted that without NRTN stimulation, STAT3-S727E expression alone did not result in neurite outgrowth (Fig. 1H) . This suggested that serine 727 phosphorylated STAT3 is required but not sufficient to induce neurite outgrowth in Neuro2A cells. Similarly, GDNF stimulation of Neuro2A-GFRα2c cells resulted in STAT3 serine but not tyrosine phosphorylation (Fig. S1D) . Transient expression of STAT3 serine (S727A) dominant negative mutant impaired GDNF induced neurite outgrowth (data not shown). These data suggested that STAT3 can be activated by both ligands and in turn mediated their neuritogenic functions. For the ease of presentation, only data on NRTN was shown for experiments described below.
RET but not NCAM mediated NRTN induced STAT3 serine phosphorylation in Neuro2A cells
Both RET and NCAM have been shown to transduce GFL signal in the presence of GFRα receptors. The involvement of these two receptors in NRTN induced STAT3 phosphorylation was subsequently investigated. Neuro2A cells were transiently transfected with siRNAs targeting RET or NCAM. Transcript expressions of RET and NCAM were profiled and both siRNAs were found to specifically suppress the respective target mRNA level by more than 80% within 24 h (Fig. 2A) . Transfection with control siRNA did not significantly affect the transcript levels of RET or NCAM. The knockdown effect was further validated by immunoblotting (Fig. S1B ). Neuro2A cells stably expressing GFRα2c were then transfected with either RET or NCAM siRNAs and subsequently exposed to NRTN. Upon ligand stimulation, sustained STAT3 serine phosphorylation was observed in all but RET-siRNA transfected cells (Fig. 2B and C) . Similarly, NRTN induced ERK phosphorylation was also abolished by RET siRNA but not NCAM or control siRNA ( Fig. 2D and E) . Furthermore, NRTN induced neurite outgrowth in Neuro2A cells stably expressing GFRα2c was attenuated only by RET-siRNA treatment but not the others (Fig. 2F and G) . Collectively, these data demonstrated that RET but not NCAM is involved in NRTN induced STAT3 phosphorylation and neurite outgrowth in Neuro2A cells.
3.4. RET9 but not RET51 was responsible for NRTN induced STAT3 serine phosphorylation in PC12 cells RET9 and RET51 are two predominant isoforms generated by alternative splicing of RET pre-mRNA. We further tested if NRTN induced STAT3 phosphorylation was mediated by a particular RET isoform, using another well-established neuronal model PC12 cells. The rat pheochromocytoma PC12 cells expressed negligible amount of both GFRα2 and RET, making it a suitable model to test the combinatorial interactions of NRTN and its receptor isoforms. PC12 cells were transfected and stably expressed combinations of GFRα2a, 2b or 2c with either RET9 or RET51. The specific expressions of the desired receptor isoform combination were confirmed by RT-qPCR (Fig. 3A) and immunoblotting ( Fig. S1A  and C) . These cells were then stimulated with NRTN and the phosphorylation of STAT3 was measured. Consistent with the observation in Neuro2A cells, NRTN stimulation of GFRα2a or 2b expressing PC12 cells did not induce significant STAT3 phosphorylation regardless of the co-expression of either RET9 or RET51 isoforms (Fig. S2A-C) . Interestingly, the combinatorial interaction of GFRα2c with RET9 but not RET51 resulted in sustained STAT3 serine but not tyrosine phosphorylation ( Fig. 3B-D) . Similar observation was made with GDNF stimulated PC12-GFRa2c-RET9 cells (Fig. S1E) . Collectively, the data from Neuro2A and PC12 cells further supported the hypothesis that NRTN and GDNF activation of STAT3 was mediated by specific combinations of GFRα2 and RET receptor isoforms. Furthermore, IL6 but not NRTN or NGF stimulation of PC12-GFRα2c-RET9 resulted in phosphorylation of Jak1 (Fig. S1F) , suggesting that NRTN activation of STAT3 was not mediated by Jak-STAT3 pathway. Since Jak was shown to be essential for STAT3 tyrosine phosphorylation [25] , the data provided a plausible explanation for the inability of NRTN to induce STAT3 tyrosine phosphorylation. 
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Ctrl Ctrl siRNA RET siRNA NCAM siRNA NRTN ** ** ** ** ** ** ** ** * Fig. 2 . RET but not NCAM mediated NRTN induced STAT3 serine phosphorylation in Neuro2A cells. A. Total RNA was extracted from Neuro2A-GFRα2c cells transiently transfected with siRNA duplex specific for RET, NCAM or control siRNA. The transcript expressions of GFRα2c, RET and NCAM quantified by RT-qPCR with standard curves and normalized by GAPDH. The effects of different siRNAs on these three genes are expressed as percentage knockdown from control cells. B-G. Neuro2A-GFRα2c transiently transfected with different siRNAs were stimulated with NRTN (50 ng/ml). NRTN induced P-Ser-STAT3 (B-C), P-ERK (D-E) and neurite outgrowth (F-G) were analyzed. Significant differences between the percentages of neurite bearing cells in control and siRNA transfected cells were calculated using the paired Student's t-test. A value of p b 0.05 was considered significant (**p b 0.01; *p b 0.05).
STAT3 serine phosphorylation was regulated by Src and ERK
Multiple signaling pathways have been implicated in STAT3 serine phosphorylation. We subsequently investigated the involvement of Src, MAPKs (ERK, JNK and p38) and PKC in NRTN induced STAT3 serine phosphorylation. Neuro2A and PC12 co-expressing GFRα2c and RET9 cells were pretreated with pharmacological inhibitors, and subsequently stimulated with NRTN for varying periods of time. Interestingly, inhibition of Src (SU6656) and ERK (U0126) but not JNK (SP600125), p38 (SB203580) or PKC (Gö6983) was found to significantly attenuate NRTN induced STAT3 serine phosphorylation, in both Neuro2A (Figs. 4A and C, S2D ) and PC12 cells (Figs. 4B and D, S2E) . It is worthy to note that JNK, which we found to mediate NGF induced STAT3 serine phosphorylation in PC12 cells, was similarly activated by NRTN but was not involved in NRTN-STAT3 signaling transduction. The data suggested that distinct combinations of signaling nodes are involved in STAT3 activation by different neurotrophic factor systems. Intriguingly, inhibition of Src and ERK but not JNK, p38 or PKC pathway attenuated NRTN induced neurite outgrowth in Neuro2A (Fig. 4E ) and PC12 cells (Fig. 4F) . The correlation between the involvements of these pathways in NRTN induced neurite outgrowth and STAT3 phosphorylation was suggestive of the role of STAT3 as a downstream mediator of neurite outgrowth.
Unexpectly, RET9 but not RET51 was found to induce Src Y416 phosphorylation ( Fig. 4G and H ) in PC12 cells. In addition, inhibition of Src attenuated RET9 mediated neurite outgrowth but not RET51 (Fig. 4I and J) .
These data showed that RET isoform specific phosphorylation of STAT3 was correlated to the differential activation of Src by RET9 but not RET51.
NRTN induced P-Ser-STAT3 was undetectable in nucleus
STAT3 is known to mediate ligand-receptor signaling through transcriptional activation of target genes. Ligand induced STAT3 nuclear translocation and its kinetics affects the temporal expressions and functions of the target genes. To test if NRTN induced STAT3 phosphorylation resulted in its nuclear translocation and target gene expression, nuclear and cytosolic fractions were prepared from control and NRTN stimulated PC12 cells. In addition, IL6, which has been shown to induce rapid nuclear translocation of STAT3 in PC12 cells [26] , was used as a control. Both NRTN and IL6 induced rapid ERK phosphorylation and its increased nuclear localization (Fig. 5A-C) . Similarly, phosphorylated STAT3 was detected in nuclear fractions within 10 min of IL6 stimulation and was sustained over 6 h (Fig. 5A, D-F) . In contrast, STAT3 was not detectable in the nucleus in cells stimulated with NRTN over the period of 6 h. Likewise, in Neuro2A cells, NRTN stimulation was found to induce nuclear localization of ERK (Fig. S3A-C) but not STAT3 (Fig. S3A, D-F) . Collectively, the observations suggested that NRTN induced STAT3 serine phosphorylation did not result in detectable nuclear localization, and that P-Ser-STAT3 may mediate NRTN induced neurite outgrowth through a transcriptional independent mechanism.
P-STAT3-Ser727
Pan 
STAT3 was localized to mitochondria and was serine phosphorylated upon NRTN stimulation
We have recently shown that NGF induced mitochondrial localization of P-Ser-STAT3 in PC12 cells [23] . In order to test the hypothesis that NRTN induced P-Ser-STAT3 may similarly be localized to the mitochondria, cytosolic and mitochondrial fractions were isolated from control and NRTN stimulated PC12 and Neuro2A cells. The presence of P-Ser-STAT3, as well as total STAT3, in each fraction was analyzed by immunoblotting. Interestingly, in both PC12 (Fig. 6A-C ) and Neuro2A cells (Fig. S4) , NRTN stimulation increased the amount of P-Ser-STAT3 detected in mitochondrial fraction but not total STAT3. These observations suggested that STAT3 may be constitutively present in mitochondria and were serine phosphorylated upon NRTN stimulation. Consistent with this suggestion is that ERK, which has been shown to phosphorylate STAT3 at serine 727 , was robustly activated in the mitochondria upon NRTN treatment (Figs. 6, S4 ). These observations supported the hypothesis that STAT3 may be phosphorylated in mitochondria by activated ERK or other kinases.
To test if mitochondrial P-Ser-STAT3 signal was due to contamination from the cytoplasm, immunoblot intensity ratios of P-Ser-STAT3 to the cytosolic marker SOD1 in mitochondria and cytosol were compared as previously described [23] . If the detected P-Ser-STAT3 in the mitochondria was due to cytosolic contamination, the ratios of P-Ser-STAT3 to SOD1 in both fractions should be similar. In PC12 cells, the intensity ratios of P-Ser-STAT3 to SOD1 in the cytosol and mitochondria at 10 min were 1.5 and 7.6 respectively (Fig. 6) . Similar observation was made in Neuro2A cells (Fig. S4) , indicating that mitochondrial P-Ser-STAT3 was not due to cytosolic contamination. In addition, the total amount of STAT3 in the mitochondria was estimated to be 11% of the cytosolic STAT3 in PC12 cells and 15% in Neuro2A cells. The ratio of mitochondrial ERK to cytosolic ERK was 22% in PC12 cells and 24% in Neuro2A cells. These data are consistent with earlier reports from both our group [23] and others [18, 27] , which provided further support to the reliability of the isolation method and the experiments.
The presence of P-Ser-STAT3 in mitochondria was further validated by immunocytochemistry. NRTN stimulation significantly increased the florescent intensity of P-Ser-STAT3 and its co-localization with specific mitochondria marker, Mito-Tracker, in both PC12 (Fig. 7A , Co-localization Coefficient = 0.343) and Neuro2A cells (Fig. S4F , Colocalization Coefficient = 0.482). Moreover, NRTN induced P-Ser-STAT3 was also found to co-localize with GRIM-19 (Figs. 7B, S4G , Co-localization Coefficient = 0.665 & 0.797 respectively), a known STAT3 binding partner and a component of the mitochondrial electron transport complex I [17, 18, 28, 29] . Consistent with the observations in cell lines, NRTN induced P-Ser-STAT3 was also found to co-localize with MitoTrakcer (Fig. 7C , Co-localization Coefficient = 0.543) as well as GRIM-19 (Fig. 7D , Co-localization Coefficient = 0.576) in primary cortical neurons. Furthermore, the co-localization of P-Ser-STAT3 with MitoTracker was observed not only in the cell body but also along the neurites (Fig. 7E) . Based on these observations, it is tempting to speculate that NRTN may regulate local mitochondrial function along neurite and in growth cone through mitochondrial localized P-Ser-STAT3. Collectively, the data from subcellular fractionation and immunocytochemical staining provided strong evidences that P-Ser-STAT3 was localized to the mitochondria of neuronal cells upon NRTN stimulation.
Mitochondrial STAT3 is an important mediator of NRTN induced neurite outgrowth
To investigate the role of mitochondrial P-Ser-STAT3 in NRTN induced neurite outgrowth, PC12 cells co-expressing GFRα2c and RET9 were stably transfected with mitochondrial targeted wild type and mutant STAT3 (MTS-STAT3). These MTS-STAT3 constructs have been used successfully to investigate the functions of mitochondrial STAT3 [18, 23, 30] and shown to specifically target the exogenously expressed STAT3 mutants to the mitochondria [23] . The effect of different MTS-STAT3 mutants on NRTN induced neurite outgrowth was examined. Remarkably, mitochondria targeted serine dominant negative mutant of STAT3 (MTS-STAT3-SA) attenuated NRTN induced neurite outgrowth (Fig. 7F-G) , while the wild type (MTS-STAT3-WT) and tyrosine dominant negative mutant (MTS-STAT3-YF) slightly enhanced NRTN induced neurite outgrowth. These results demonstrated the active role of mitochondrial P-Ser-STAT3 in mediating NRTN induced neurite outgrowth. 
Discussion
This study demonstrated the novel functions of the alternatively spliced receptor isoform GFRα2c and RET9 in mediating NRTN induced STAT3 serine phosphorylation. Unlike previous studies on oncogenic RET, this is the first report of the activation of STAT3 by a GDNF family ligand through GFRα and wild type RET. Furthermore, P-Ser-STAT3 was found to localize to the mitochondria instead of the nucleus and mediated NRTN induced neurite outgrowth independent of its transcriptional activities.
Recent study has found 92-94% of human genes to be alternatively spliced [31] . In many systems, alternative splicing has produced multiple isoforms with distinct biochemical properties, thus allowing a single gene to exert a diverse range of biological functions [32] . Among different tissues, it was found that the greatest amount of conserved alternative splicing occurs in the central nervous system [33] . Our group has previously identified three distinct spliced isoforms of GFRα2, the canonical receptor for NRTN [8] . The three isoforms were further shown to mediate differential signalling activation and exerted opposing neuritogenic functions. NRTN activation of GFRα2b inhibited neurite outgrowth whereas GFRα2a and 2c induced neurite outgrowth [10] . Using exon-overlapping qPCR assays that specifically detect each of the isoforms [34] , we have shown that all three isoforms are highly expressed in the cortex [10] , the region of the brain involved in learning complex tasks. This is consistent with the observation that GFRα2 knockout mice show significant impairment in memory tasks [35] . Moreover, NRTN has also been shown to provide both functional and structural neuroprotection for cortical neurons in mouse model of Huntington's Disease [24] . However, the signalling mechanisms underlying NRTN functions in cortical neurons and the roles of different GFRα2 isoforms have yet to be thoroughly investigated.
In cultured embryonic cortical neurons, NRTN stimulation resulted in rapid phosphorylation of ERK and STAT3 serine but not tyrosine residue. A classic transcription regulator, STAT3 was first discovered as a key mediator of cytokine induced inflammation and immunity [36, 37] . Later studies have found STAT3 to regulate a much wider range of biological processes including neuritogenesis and neuroprotection [13] . In cortical neurons, NRTN signaling is thought to be mediated by GFRα2, which were shown to be highly expressed in the cortex [10, 38] , through co-receptors RET and/ or NCAM. While selected early studies have suggested the lack of RET expression in the cortex of adult and neonatal rats [38, 39] , more recent publications have reported the presence of RET in both embryonic and adult cortical neurons [40, 41] . This is consistent with our findings, using real-time quantitative PCR, that both RET isoforms were expressed in cultured embryonic day 18 cortical neurons. To investigate the mechanism of NRTN activation of STAT3 and the role of receptor isoforms, we engineered two well used neuronal models to express different combinations of GFRα2 and RET receptor isoforms. Intriguingly, the shortest isoform GFRα2c but not GFRα2a or 2b was able to mediate sustained STAT3 serine phosphorylation upon NRTN stimulation. GFRα receptor has been partially crystallized and is thought to be structurally organized into three distinct domains [42] [43] [44] . GFRα2c, with exon 2 and 3 deletion [8] , differs from the other two isoforms in its N terminus domain, which has been shown to be dispensable for ligand binding [45] . This is consistent with our earlier findings that GFL bound equally well to all three GFRα2 isoforms in Neuro2A cells [10] . To explain the distinct functions of these isoforms, we postulated that the N-terminal domain may be an important determinant of the overall conformation of the GFL-GFRα-RET/NCAM complex and the preferential activation of certain downstream signalling pathways. This is supported by recent findings that the N-terminal domain of GFRα1 is important for the interactions with co-receptor RET [46] and NCAM [47] . Co-crystallization of the entire GFL-GFRα-RET/NCAM complexes containing different isoforms would provide the most direct means of investigating the impact of the isoform specific N-terminal domain. This is becoming increasingly feasible with the advancement in protein crystallization technologies. As an alternative means, we are currently investigating the phosphorylation patterns of co-receptor RET when coupled to different GFRα2 isoforms, in an attempt to provide further insights into their distinct biochemical properties. Nonetheless, our finding that GFRα2c but not 2a or 2b was capable to inducing STAT3 phosphorylation provided further evidence to the distinct functions of the GFRα2 receptor isoforms [9, 10] .
In addition, ligand bound GFRα has been shown to either partner with RET or NCAM to transduce its signals. NCAM but not RET was found to mediate GFRα1b isoform induced glioma migration [48] . In contrast, this study found RET but not NCAM to mediate NRTN induced STAT3 phosphorylation and neurite outgrowth, even though the expression level of NCAM in Neuro2A cells was significantly greater than RET. These data suggested that the selective partnering of GFRα with its co-receptors vary in a cell context dependent manner and was not determined solely by the expression levels of different co-receptors. Furthermore, the alternatively spliced isoform RET9 but not RET51 was found to mediate NRTN induced STAT3 phosphorylation. The two RET tyrosine kinase isoforms share 16 identical tyrosine residues but RET51 contains two additional tyrosine residues in the carboxyl terminal (tyrosine 1090 and 1096). Mounting evidences have demonstrated the distinct functions of RET9 and 51 in different cell types. RET9 but not RET51 was able to promote tube formation of epithelial cells [49] . In contrast, RET51 but not RET9 was found to promote the survival and tubulogenesis of mouse inner medullary collecting duct cells [50] , suggestive of isoform-specific roles in embryo development and organogenesis. Other studies have reported RET9 and RET51 to engage distinct adaptor proteins and activate different signalling pathways [11, 51, 52] . In PC12 cells, NRTN activation of RET9 but not RET51 was found to induce phosphorylation of Src, an important signalling intermediate that mediated STAT3 phosphorylation, thus providing a plausible explanation for RET9 specific activation of STAT3. Whether GFRα2 and RET isoforms are specifically expressed in selected populations of cortical neurons and induce targeted STAT3 phosphorylation during development are currently being investigated. Such data would further elucidate the temporal and spatial role of NRTN receptor isoforms and STAT3 in neural development.
To date, the functional significance of STAT3 serine phosphorylation remains controversial. It has been shown to either enhance or suppress the transcriptional activity of tyrosine phosphorylated STAT3. More recently, we and others have shown that serine mono-phosphorylated STAT3 could function independent of its transcriptional activities. The observation that NRTN induced P-Ser-STAT3 did not localize to the nucleus added further evidence to this body of knowledge. Our findings that NRTN induced P-Ser-STAT3 was localized to the mitochondria in both Neuro2A and PC12 cells are in congruence with our earlier report where NGF induced mitochondrial STAT3 phosphorylation [23] . These new data suggested that the involvement of mitochondrial STAT3 in neurite outgrowth is not restricted to NGF, but may be a common mechanism shared by multiple neurotrophic factors. It is intriguing that PSer-STAT3 was localized to the mitochondria not only in the cell body but along the neurites as well. As neurite outgrowth is a dynamic and reversible process and is influenced by local mitochondrial dynamics [53] [54] [55] , it is tempting to speculate that mitochondrial P-Ser-STAT3 may be an important transducer of the anterograde and/or retrograde signaling of neurotrophic factors along neurites.
To the best of our knowledge, this study marked the first report of the activation of STAT3 by a ligand (NRTN) activated GFRα and the non-oncogenic RET receptor. It further demonstrated that STAT3 serine phosphorylation was mediated specifically by receptor isoform GFRα2c and RET9. P-Ser-STAT3 was intimately involved in NRTN induced neurite outgrowth, in a transcription independent manner, through its spatial localization to the mitochondria. Taken together, this study provided novel insights into an intriguing role of receptor isoforms in mediating NRTN induced mitochondrial STAT3 and neurite outgrowth.
